Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Kyasanura forest disease (KFD), caused by the KFD virus, is an arbovirus characterized by an initial fever, headache and myalgia that can progress to a hemorrhagic disease and that in some cases is followed by a second phase characterized by neurological manifestations.
Biomarker and diagnostic research for Kyasanur forest disease has been reported in the published literature.
No clinical trials have been registered for Kyasanur forest disease.
228 publications have been identified in PubMed for Kyasanur forest disease. Research spans Review / Meta-Analysis (34%), Basic Science / Preclinical (31%), and Epidemiology / Natural History (18%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 66 | 34% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 2:53 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Kyasanur forest disease
59 |
31% |
Disease patterns and progression | 35 | 18% |
Patient case studies | 14 | 7% |
Clinical study results | 7 | 4% |
New treatment approaches | 7 | 4% |
Testing and diagnosis research | 4 | 2% |
Hafeez S (2026). [PMID: 41578914](https://pubmed.ncbi.nlm.nih.gov/41578914/). *Journal of medical virology*. [Epidemiology / Natural History]
Narayanan J (2026). [PMID: 41806035](https://pubmed.ncbi.nlm.nih.gov/41806035/). *Archives of virology*. [Basic Science / Preclinical]
David C (2026). [PMID: 41395910](https://pubmed.ncbi.nlm.nih.gov/41395910/). *Ann Rheum Dis*. [Epidemiology / Natural History]
Amarapathy S (2026). [PMID: 41986011](https://pubmed.ncbi.nlm.nih.gov/41986011/). *Prog Mol Biol Transl Sci*. [Review / Meta-Analysis]
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Ann Allergy Asthma Immunol*. [Review / Meta-Analysis]
Hoellinger B (2026). [PMID: 41242395](https://pubmed.ncbi.nlm.nih.gov/41242395/). *Infect Dis Now*. [Review / Meta-Analysis]
Huang Y (2026). [PMID: 41544799](https://pubmed.ncbi.nlm.nih.gov/41544799/). *Metabolism*. [Epidemiology / Natural History]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Basic Science / Preclinical]
Biemond JJ (2026). [PMID: 41908251](https://pubmed.ncbi.nlm.nih.gov/41908251/). *Lancet Reg Health Southeast Asia*. [Epidemiology / Natural History]
Sunagar R (2026). [PMID: 42004966](https://pubmed.ncbi.nlm.nih.gov/42004966/). *Front Immunol*. [Basic Science / Preclinical]